L. Dorigotti

699 total citations
34 papers, 539 citations indexed

About

L. Dorigotti is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, L. Dorigotti has authored 34 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 13 papers in Molecular Biology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in L. Dorigotti's work include Neuroscience and Neuropharmacology Research (8 papers), Synthesis and biological activity (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). L. Dorigotti is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Synthesis and biological activity (4 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). L. Dorigotti collaborates with scholars based in Italy and United States. L. Dorigotti's co-authors include M. Gaetani, O Bellini, M Soldati, A. Glässer, Aurelio Di Marco, C. Semeraro, Mauro Magnani, Mario Pinza, F. Ponzio and Alberto Cerri and has published in prestigious journals such as Journal of Medicinal Chemistry, Cellular and Molecular Life Sciences and Psychopharmacology.

In The Last Decade

L. Dorigotti

31 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Dorigotti Italy	14	215	141	110	103	79	34	539
W. Lippmann United States	16	222 1.0×	86 0.6×	204 1.9×	178 1.7×	44 0.6×	71	719
Takeshi Honma Japan	16	196 0.9×	58 0.4×	164 1.5×	35 0.3×	81 1.0×	54	837
Andrew D. Gribble United Kingdom	14	362 1.7×	88 0.6×	177 1.6×	41 0.4×	131 1.7×	20	674
Mary Lou Torchiana United States	13	342 1.6×	131 0.9×	160 1.5×	48 0.5×	29 0.4×	38	656
Jo Mori Japan	17	346 1.6×	173 1.2×	210 1.9×	95 0.9×	65 0.8×	66	945
Bernard Levet‐Trafit Switzerland	9	379 1.8×	142 1.0×	273 2.5×	87 0.8×	79 1.0×	9	727
Takashi Nose Japan	12	198 0.9×	62 0.4×	101 0.9×	69 0.7×	36 0.5×	59	514
A. M. Simonis Netherlands	10	258 1.2×	54 0.4×	142 1.3×	60 0.6×	36 0.5×	18	545
Beverley Hammond United Kingdom	9	145 0.7×	66 0.5×	96 0.9×	91 0.9×	89 1.1×	11	418
N. N. Share Canada	14	139 0.6×	51 0.4×	115 1.0×	81 0.8×	21 0.3×	33	541

Countries citing papers authored by L. Dorigotti

Since Specialization

Citations

This map shows the geographic impact of L. Dorigotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Dorigotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Dorigotti more than expected).

Fields of papers citing papers by L. Dorigotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Dorigotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Dorigotti. The network helps show where L. Dorigotti may publish in the future.

Co-authorship network of co-authors of L. Dorigotti

This figure shows the co-authorship network connecting the top 25 collaborators of L. Dorigotti. A scholar is included among the top collaborators of L. Dorigotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Dorigotti. L. Dorigotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Campo, Giuseppe M., Stefano Ceccarelli, Francesco Squadrito, et al.. (1997). Raxofelast (IRFI 016): A New Hydrophilic Vitamin E‐Like Antioxidant Agent. Cardiovascular Drug Reviews. 15(2). 157–173. 13 indexed citations

Pinza, Mario, et al.. (1993). Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo[1,2-a]imidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers. Journal of Medicinal Chemistry. 36(26). 4214–4220. 61 indexed citations

Magnani, Mauro, et al.. (1992). Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze. Psychopharmacology. 106(2). 175–178. 19 indexed citations

Brunetti, M., Lucilla Parnetti, Gianna Evelina De Medio, et al.. (1989). The effect of oxiracetam treatment on alterations of lipid metabolism in brain areas from spontaneously hypertensive rats. Pharmacological Research. 21(3). 313–323. 1 indexed citations

Ponzio, F., Pietro Belfiore, & L. Dorigotti. (1989). Effect of oxiracetam on cerebral cholinergic imbalance secondary to an nmda-receptor blockade. Pharmacological Research. 21. 103–104. 4 indexed citations

Ponzio, F., et al.. (1989). Brain Entry and Direct Central Pharmacological Effects of the Nootropic Drug Oxiracetam. Pharmacopsychiatry. 22(S 2). 111–115. 25 indexed citations

Semeraro, C., et al.. (1989). Renal function studies with cadralazine in conscious dogs: A comparison with hydralazine. Pharmacological Research. 21(2). 211–222. 3 indexed citations

Dorigotti, L., et al.. (1988). Behavioural screening for potential nootropic drugs. Pharmacological Research Communications. 20. 315–315. 4 indexed citations

Dorigotti, L., et al.. (1986). Experimental Behavioral Studies with Oxiracetam on Different Types of Chronic Cerebral Impairment. Clinical Neuropharmacology. 9. S19–26. 24 indexed citations

10.

Dorigotti, L., et al.. (1984). Methylazoxymethanol microencephaly in rats: neurochemical characterization and behavioral studies with the nootropic oxiracetam.. PubMed. 16(1). 67–83. 37 indexed citations

11.

Musci, Robert V., et al.. (1982). Antiulcer and mineralocorticoid activities of carbenoxolone and desoxycorticosterone in rats. Journal of Pharmacy and Pharmacology. 34(8). 517–519. 1 indexed citations

12.

Dorigotti, L. & C. Semeraro. (1980). Renal function studies with propildazine alone and in combination with propranolol in dogs. European Journal of Pharmacology. 67(2-3). 275–282. 3 indexed citations

13.

Dorigotti, L., et al.. (1979). [3-Hydrazinepyridazine derivatives. III. Synthesis and anti-hypertensive activity of new 3-(2-acylhydrazine)-pyridazine-6-alkylamino substitutes].. PubMed. 34(4). 299–310. 3 indexed citations

14.

Dorigotti, L., et al.. (1977). ChemInform Abstract: 2,6‐DIALKYLPIPERAZINES. VIII. N1‐ARYLALKYL‐N4‐(2′‐PYRIDYL)‐2,6‐DIMETHYLPIPERAZINES AS ADRENOLYTIC AND VASODILATOR AGENTS. Chemischer Informationsdienst. 8(36). 296–302.

15.

Dorigotti, L., et al.. (1974). Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.. PubMed. 52(3). 459P–459P. 3 indexed citations

16.

Dorigotti, L., M. Gaetani, A. Glässer, & E Turolla. (1969). Competitive antagonism of isoprenaline-induced cardiac necroses by β-adrenoreceptor blocking agents. Journal of Pharmacy and Pharmacology. 21(3). 188–191. 9 indexed citations

17.

Dorigotti, L., et al.. (1968). Vasodilating and alpha-receptor blocking activity of a new ergoline derivative.. PubMed. 34(3). 700P–700P. 17 indexed citations

18.

Dorigotti, L. & A. Glässer. (1968). Comparative effects of caerulein, pancreozymin and secretin on pancreatic blood flow. Cellular and Molecular Life Sciences. 24(8). 806–807. 17 indexed citations

19.

Gaetani, M., et al.. (1963). [EXPERIMENTAL STUDIES OF THE ANTINEOPLASTIC ACTIVITY OF A NEW ANTIBIOTIC, DAUNOMYCIN].. PubMed. 49. 203–17. 67 indexed citations

20.

Marco, Aurelio Di, M. Gaetani, L. Dorigotti, & O Bellini. (1962). Activity of 4 Beta-Hydroxy-17 Alpha-Methyl-19-Nortestosterone on Experimental Tumors. Tumori Journal. 48(5). 361–372. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact